Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-01-03 @ 10:08 PM
Study NCT ID:
NCT02012959
Status:
TERMINATED
Last Update Posted:
2018-09-26
First Post:
2013-12-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-22
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-24
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-11
First Submit QC Date:
None
Study First Post Date:
2013-12-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-31
Results First Submit QC Date:
None
Results First Post Date:
2018-08-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-29
Last Update Post Date:
2018-09-26
Last Update Post Date Type:
ACTUAL